LumaCyte today announced that its analytical approach has been included in the newly published International Organization for Standardization (ISO) global standard for gene delivery systems, ISO 16921 ...
Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery to improve treatments for patients, today announced that ...
CHARLOTTESVILLE, Va., March 31, 2026--(BUSINESS WIRE)--LumaCyte today announced that its analytical approach has been included in the newly published International Organization for Standardization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results